Awarded
1 - L1_ELTROMBOPAG (DOE) 25 mg y 50 mg
Original language: Spanish
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Winners
- CIPLA EUROPE NV Sucursal en España, GLENMARK FARMACÉUTICA, S.L.U., KERN PHARMA, S.L., REDDY PHARMA IBERIA, S.A., TARBIS FARMA SL, TEVA PHARMA, S.L, VIATRIS PHARMACEUTICALS, S.L., VIVANTA GENERICS S.R.O. SUCURSAL EN ESPAÑA
- Contract value
- €147,840
- Bids received
- 8
- Published
- 7 Apr 2026
- Awarded
- 1 Apr 2026
- Contract start
- 1 Apr 2026
- Contract end
- 18 Apr 2027estimated
- Region
- Araba/Álava